Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sanofi SA    SAN   FR0000120578

SANOFI SA

(SAN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi SA
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:

- pharmaceutical products (84.1%): for the treatment of cardio-vascular diseases, thrombosis, central nervous system disorders (insomnia, multiple sclerosis, epilepsy), cancers, allergies, etc. Moreover, Sanofi-Aventis markets OTC products and generic drugs;

- human vaccines (15.9%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas.

At the end of 2019, the group had 81 production sites throughout the world.

Net sales are distributed geographically as follows: Europe (24.5%), United States (35.3%), Asia (12.2%), Latin America (7.6%), Africa and Middle East (6.4%) and other (14%).

Number of employees : 100 409 people.
Sales per Business
20182019Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals24,68571.6%25,70871.2% +4.14%
Vaccines5,11814.9%5,73115.9% +11.98%
Consumer Healthcare4,66013.5%4,68713% +0.58%
Sales per region
2019
EUR (in Million)%
United States12,75635.3%
Europe6,59118.2%
Asia4,39312.2%
Latin America2,7347.6%
Africa and Middle East2,3076.4%
France2,2616.3%
Japan1,9085.3%
Eurasia1,3123.6%
Rest of the World1,2473.5%
South Korea449.001.2%
Managers
NameAgeSinceTitle
Paul Hudson522019Chief Executive Officer & Director
Serge Weinberg692015Chairman
Jean-Baptiste Chasseloup de Chatillon552018Chief Financial Officer & Executive Vice President
John C. Reed, Dr.61-EVP & Global Head-Research & Development
Nestle Frank-2016Global Head-Immunology Therapeutic Research Area
Dietmar P. Berger, Dr.--Chief Medical Officer & Global Head-Development
Carole Piwnica622011Independent Director
Laurent Attal, Dr.622012Director
Fabienne Lecorvaisier572013Independent Director
Patrick Kron662014Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,253,846,111 1,116,725,376 89.1% 19,481 0.0% 89.1%
Shareholders
NameEquities%
L'Oréal S.A. 118,227,307 9.41%
The Vanguard Group, Inc. 32,992,590 2.63%
Norges Bank Investment Management 26,690,482 2.12%
Fidelity Management & Research Co. LLC 21,139,779 1.68%
Plan d'Epargne Entreprise Sanofi Synthelabo 20,371,851 1.62%
Dodge & Cox 17,391,749 1.38%
Lyxor International Asset Management SAS 15,232,738 1.21%
Amundi Asset Management SA (Investment Management) 14,232,736 1.13%
BNP Paribas Asset Management France SAS 11,110,905 0.88%
FIL Investment Advisors (UK) Ltd. 10,729,132 0.85%
Holdings
NameEquities%Valuation
Sanofi India Limited (500674) 13,909,58760.4%1,418,877,606 USD
Sanofi SA (SAN) 3,101,3360.25%301,958,478 USD
Regeneron Pharmaceuticals (REGN) 279,7660.25%171,443,402 USD
Fulcrum Therapeutics, Inc. (FULC) 558,0352.39%11,110,477 USD
Qualigen Therapeutics, Inc. (QLGN) 79,2090.63%510,898 USD
Unum Therapeutics, Inc. 842,0482.70%472,389 USD
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment A
- CAC 40 / CAC All Shares, CAC All-Tradable, CAC Large 60, Euro Stoxx 50, Euronext 100, Euronext® CDP Environment France EW, Euronext® CDP Environment France Ex Oil, FTSE Eurotop 100, Low Carbon 100 Europe, PEA, Stoxx Europe 50, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
Company contact information
Sanofi SA
54 Rue la Boétie
FR-75008 Paris
France

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
Internet : http://www.sanofi.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Sanofi SA
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SANOFI1.47%129 537
JOHNSON & JOHNSON-0.45%382 569
ROCHE HOLDING AG7.29%304 280
PFIZER, INC.-10.13%195 586
MERCK & CO., INC.-14.95%195 239
NOVARTIS AG-10.58%192 304
ABBVIE INC.10.53%172 463
NOVO NORDISK A/S12.38%154 620
AMGEN INC.3.72%147 085
ELI LILLY AND COMPANY23.32%146 917
ASTRAZENECA PLC12.63%141 808
BRISTOL-MYERS SQUIBB COMPANY-10.03%130 670
GLAXOSMITHKLINE PLC-10.21%100 280
CHUGAI PHARMACEUTICAL CO., LTD.60.71%82 699
JIANGSU HENGRUI MEDICINE CO., LTD.36.86%75 390
BAYER AG-11.41%72 015
ALLERGAN PLC0.97%63 659
TAKEDA PHARMACEUTICAL COMPANY LIMITED-14.08%54 055
DAIICHI SANKYO COMPANY, LIMITED18.65%51 815
ASTELLAS PHARMA INC.-6.74%30 202
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED42.66%28 217